Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada
- PMID: 12925421
- PMCID: PMC180651
Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada
Abstract
Background: Severe acute respiratory syndrome (SARS) was introduced into Canada by a visitor to Hong Kong who returned to Toronto on Feb. 23, 2003. Transmission to a family member who was later admitted to a community hospital in Toronto led to a large nosocomial outbreak. In this report we summarize the preliminary results of the epidemiological investigation into the transmission of SARS between 128 cases associated with this hospital outbreak.
Methods: We collected epidemiologic data on 128 probable and suspect cases of SARS associated with the hospital outbreak, including those who became infected in hospital and the next generation of illness arising among their contacts. Incubation periods were calculated based on cases with a single known exposure. Transmission chains from the index family to hospital contacts and within the hospital were mapped. Attack rates were calculated for nurses in 3 hospital wards where transmission occurred.
Results: The cases ranged in age from 21 months to 86 years; 60.2% were female. Seventeen deaths were reported (case-fatality rate 13.3%). Of the identified cases, 36.7% were hospital staff. Other cases were household or social contacts of SARS cases (29.6%), hospital patients (14.1%), visitors (14.1%) or other health care workers (5.5%). Of the 128 cases, 120 (93.8%) had documented contact with a SARS case or with a ward where there was a known SARS case. The remaining 8 cases without documented exposure are believed to have had exposure to an unidentified case and remain under investigation. The attack rates among nurses who worked in the emergency department, intensive care unit and coronary care unit ranged from 10.3% to 60.0%. Based on 42 of the 128 cases with a single known contact with a SARS case, the mean incubation period was 5 days (range 2 to 10 days).
Interpretation: Evidence to date suggests that SARS is a severe respiratory illness spread mainly by respiratory droplets. There has been no evidence of further transmission within the hospital after the elapse of 2 full incubation periods (20 days).
Figures
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/180651/bin/18FF1.gif)
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/180651/bin/18FF2.gif)
Comment in
-
Mild SARS in elderly patients.CMAJ. 2004 Mar 16;170(6):927. doi: 10.1503/cmaj.1031734. CMAJ. 2004. PMID: 15023903 Free PMC article. No abstract available.
Similar articles
-
Investigation of the second wave (phase 2) of severe acute respiratory syndrome (SARS) in Toronto, Canada. What happened?Can Commun Dis Rep. 2008 Feb;34(2):1-11. Can Commun Dis Rep. 2008. PMID: 18404809 English, French.
-
The SARS outbreak in a general hospital in Tianjin, China -- the case of super-spreader.Epidemiol Infect. 2006 Aug;134(4):786-91. doi: 10.1017/S095026880500556X. Epub 2005 Dec 22. Epidemiol Infect. 2006. PMID: 16371174 Free PMC article.
-
Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto.N Engl J Med. 2004 Jun 3;350(23):2352-61. doi: 10.1056/NEJMoa032111. N Engl J Med. 2004. PMID: 15175437
-
Severe acute respiratory syndrome.Int J Tuberc Lung Dis. 2003 Dec;7(12):1117-30. Int J Tuberc Lung Dis. 2003. PMID: 14677886 Review.
-
[SARS: a new emergency in the world health].Recenti Prog Med. 2003 Jul-Aug;94(7-8):284-94. Recenti Prog Med. 2003. PMID: 12868233 Review. Italian.
Cited by
-
Natural evidence of coronaviral 2'-O-methyltransferase activity affecting viral pathogenesis via improved substrate RNA binding.Signal Transduct Target Ther. 2024 May 29;9(1):140. doi: 10.1038/s41392-024-01860-x. Signal Transduct Target Ther. 2024. PMID: 38811528 Free PMC article.
-
Human behavior in the time of COVID-19: Learning from big data.Front Big Data. 2023 Apr 6;6:1099182. doi: 10.3389/fdata.2023.1099182. eCollection 2023. Front Big Data. 2023. PMID: 37091459 Free PMC article. Review.
-
Current SARS-CoV-2 Protective Strategies for Healthcare Professionals.Biomedicines. 2023 Mar 7;11(3):808. doi: 10.3390/biomedicines11030808. Biomedicines. 2023. PMID: 36979786 Free PMC article. Review.
-
Transmission visualizations of healthcare infection clusters: A scoping review.Antimicrob Steward Healthc Epidemiol. 2022 Jun 15;2(1):e92. doi: 10.1017/ash.2022.237. eCollection 2022. Antimicrob Steward Healthc Epidemiol. 2022. PMID: 36483443 Free PMC article.
-
A comparative overview of SARS-CoV-2 and its variants of concern.Infez Med. 2022 Sep 1;30(3):328-343. doi: 10.53854/liim-3003-2. eCollection 2022. Infez Med. 2022. PMID: 36148164 Free PMC article. Review.
References
-
- Tsang K, Ho P, Ooi G, Yee W, Wang T, Chan-Yeung M, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348(20):1977-85. - PubMed
-
- Ksiazek T, Erdman D, Goldsmith C, Zaki S, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348(20):1953-66. - PubMed
-
- Drosten C, Gunther S, Preiser W, van der Werf S, Brodt H, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348(20):1967-76. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous